Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Brawer

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
BJU International|March 27, 2003
Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the Early Prostate Cancer ProgramM K Brawer
CA: a Cancer Journal for Clinicians|February 24, 2001
Prostate-specific antigen: current statusM K Brawer
Seminars in Surgical Oncology|January 5, 2000
Prostate-specific antigenM K Brawer
CA: a Cancer Journal for Clinicians|May 1, 1995
How to use prostate-specific antigen in the early detection or screening for prostatic carcinomaM K Brawer
Urology|December 1, 1989
Prostatic intraepithelial neoplasia and prostate-specific antigenM K Brawer
Cancer Treatment and Research|January 1, 1992
The role of radiotherapy following radical prostatectomyM K Brawer
Cancer|September 10, 1998
Predicting outcomes of therapy for prostate carcinoma patientsM K Brawer
Reviews in Urology|September 21, 2006
The evolution of hormonal therapy for prostatic carcinomaM K Brawer
The Urologic Clinics of North America|November 1, 1990
Laboratory studies for the detection of carcinoma of the prostateM K Brawer
Journal of Clinical Pharmacology|September 1, 1993
The role of alpha 1-blockade in benign prostatic hyperplasiaM K Brawer
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
BJU International|March 27, 2003
Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the Early Prostate Cancer ProgramM K Brawer
CA: a Cancer Journal for Clinicians|February 24, 2001
Prostate-specific antigen: current statusM K Brawer
Seminars in Surgical Oncology|January 5, 2000
Prostate-specific antigenM K Brawer
CA: a Cancer Journal for Clinicians|May 1, 1995
How to use prostate-specific antigen in the early detection or screening for prostatic carcinomaM K Brawer
Urology|December 1, 1989
Prostatic intraepithelial neoplasia and prostate-specific antigenM K Brawer
Cancer Treatment and Research|January 1, 1992
The role of radiotherapy following radical prostatectomyM K Brawer
Cancer|September 10, 1998
Predicting outcomes of therapy for prostate carcinoma patientsM K Brawer
Reviews in Urology|September 21, 2006
The evolution of hormonal therapy for prostatic carcinomaM K Brawer
The Urologic Clinics of North America|November 1, 1990
Laboratory studies for the detection of carcinoma of the prostateM K Brawer
Journal of Clinical Pharmacology|September 1, 1993
The role of alpha 1-blockade in benign prostatic hyperplasiaM K Brawer
Pageof 14